<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001856'>Myocarditis</z:mp> and subsequent <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> are major causes of <z:hpo ids='HP_0001635'>heart failure</z:hpo> in young adults </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0001856'>Myocarditis</z:mp> in humans is highly <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> in etiology </plain></SENT>
<SENT sid="2" pm="."><plain>Recent studies have indicated that a subgroup of <z:mp ids='MP_0001856'>myocarditis</z:mp> patients may benefit from immune-targeted therapies, because <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> plays an important role in <z:mp ids='MP_0001856'>myocarditis</z:mp> as well as contributing to the progression to <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Suppressor of cytokine signaling (SOCS) 1 plays a key role in the negative regulation of both TLR- and cytokine receptor-mediated signaling, which is involved in innate immunity and subsequent adaptive immunity </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, we investigated the therapeutic effect of SOCS1 DNA administration on experimental autoimmune <z:mp ids='MP_0001856'>myocarditis</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e>) in mice </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> was induced by s.c. immunization with cardiac-specific <z:chebi fb="7" ids="16670">peptides</z:chebi> derived from Î± myosin H chain in BALB/c mice </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast to control <z:mp ids='MP_0001856'>myocarditis</z:mp> mice, SOCS1 DNA-injected mice were protected from development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> and <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>SOCS1 DNA administration was effective for reducing the activation of autoreactive CD4(+) T cells by inhibition of the function of Ag-presenting dendritic cells </plain></SENT>
<SENT sid="8" pm="."><plain>Our findings suggest that SOCS1 DNA administration has considerable therapeutic potential in individuals with autoimmune <z:mp ids='MP_0001856'>myocarditis</z:mp> and <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> </plain></SENT>
</text></document>